Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) administration in healthy volunteers (2012)
- Authors:
- USP affiliated authors: CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; ZUARDI, ANTONIO WALDO - FMRP
- Unidade: FMRP
- DOI: 10.2174/138161212802884780
- Subjects: CANNABIS (EFEITOS); FARMACOLOGIA; ANSIEDADE
- Language: Inglês
- Imprenta:
- Source:
- Título: Current Phamaceutical Design
- ISSN: 1873-4286
- Volume/Número/Paginação/Ano: v. 18, n. 32, p. 4966-4979, 2012
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
MARTÍN-SANTOS, R. et al. Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) administration in healthy volunteers. Current Phamaceutical Design, v. 18, n. 32, p. 4966-4979, 2012Tradução . . Disponível em: https://doi.org/10.2174/138161212802884780. Acesso em: 06 maio 2026. -
APA
Martín-Santos, R., Crippa, J. A. de S., Batalla, A., Bhattacharyya, S., Atakan, Z., Borgwardt, S., et al. (2012). Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) administration in healthy volunteers. Current Phamaceutical Design, 18( 32), 4966-4979. doi:10.2174/138161212802884780 -
NLM
Martín-Santos R, Crippa JA de S, Batalla A, Bhattacharyya S, Atakan Z, Borgwardt S, Allen P, Seal M, Langohr K, Faré M, Zuardi AW, McGuire PK. Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) administration in healthy volunteers [Internet]. Current Phamaceutical Design. 2012 ; 18( 32): 4966-4979.[citado 2026 maio 06 ] Available from: https://doi.org/10.2174/138161212802884780 -
Vancouver
Martín-Santos R, Crippa JA de S, Batalla A, Bhattacharyya S, Atakan Z, Borgwardt S, Allen P, Seal M, Langohr K, Faré M, Zuardi AW, McGuire PK. Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) administration in healthy volunteers [Internet]. Current Phamaceutical Design. 2012 ; 18( 32): 4966-4979.[citado 2026 maio 06 ] Available from: https://doi.org/10.2174/138161212802884780 - Induction of psychosis by Δ9- Tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience precessing
- Cannabis affects people differently: inter-subject variation in the psychotogenic effects of ''delta' POT.9'-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers
- A conversion of oral cannabidiol to delta9-tetrahydrocannabinol seems not to occur in humans
- Cannabidiol is a potential therapeutic for the affective-motivational dimension of incision pain in rats
- Uso de maconha e ansiedade
- Distinct effects of 'delta'9-Tetrahydrocannabinol and cannabidiol on neural activation during emotional processing
- Opposite effects of 'delta'-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology
- Modulation of effective connectivity during emotional processing by ''DELTA' POT.9'-tetrahydrocannabinol and cannabidiol
- Duloxetine in the treatment of panic disorder
- Antidepressant-like and anxiolytic-like effects of Cannabidiol: a chemical compound of Cannabis sativa
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
